Valneva

Valneva EBITDA per Share

The EBITDA per Share of Valneva (VLA.PA) as of Oct 19, 2026 is -0.47 EUR. In the previous year, EBITDA per Share was 0.13 EUR — a change of -468.76% (lower).

EBITDA per Share

-0.47EUR

YoY

-468.76%

Last updated:

EBITDA per Share of Valneva is 2025 -0.47 EUR. EBITDA per Share of Valneva was 2024 0.13 EUR. It decreases by -468.76% lower compared to the previous year.

The Valneva EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
0.12 EUR
Jan 1, 2019
0.06 EUR
Jan 1, 2020
-0.54 EUR
Jan 1, 2021
-0.47 EUR
Jan 1, 2022
-0.88 EUR
Jan 1, 2023
-0.52 EUR
Jan 1, 2024
0.13 EUR
Jan 1, 2025
-0.47 EUR
The Valneva EBITDA per Share history
YEAREBITDA per ShareYoY
-0.47EUR-468.76%
0.13EUR-124.53%
-0.52EUR-40.62%
-0.88EUR+84.71%
-0.47EUR-12.34%
-0.54EUR-934.29%
0.06EUR-43.67%
0.12EUR+29.36%
0.09EUR-647.69%
-0.02EUR-88.19%
-0.14EUR+10.15%
-0.12EUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valneva Stock analysis

What does Valneva do? Valneva SE is a biopharmaceutical company specializing in the development, production, and marketing of vaccines for humans and animals. The company was founded in 2013 through the merger of French biotech company Vivalis and Austrian biotech company Intercell. Valneva focuses on developing vaccines for infectious diseases with a significant global burden but limited commercial demand. They work closely with governments and international organizations to improve access to their vaccines in developing countries. Valneva also has a strong presence in the animal vaccine market, producing vaccines for diseases in livestock and pets. They have developed and marketed several vaccines, including Ixiaro for Japanese encephalitis and VLA15, a vaccine candidate for Lyme disease. Overall, Valneva is an international company with an impressive pipeline of vaccine candidates and a commitment to addressing global health needs. Valneva is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valneva stock

EBITDA per Share of Valneva is -0.47 EUR in 2025.

EBITDA per Share of Valneva changed from 0.13 EUR to -0.47 EUR, representing a -468.76% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Valneva since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Valneva

All Key Metrics — Valneva